home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Biotricity, Inc. - Common Stock (NQ:BTCY)

0.4631 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biotricity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology ↗

July 25, 2023

The integration of AI technology in healthcare has revolutionized the industry, particularly in the areas of automation, big data analytics, and optimization. AI-powered software is designed to assist...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 25, 2023

Via Benzinga

Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications

July 25, 2023

Via ACCESSWIRE

Biotricity Regains Nasdaq Listing Compliance

July 21, 2023

Via ACCESSWIRE

Biotricity Reports Strong Start to Fiscal Year 2024

July 06, 2023

Via ACCESSWIRE

Biotricity Predicted To Achieve 44% Annual Growth Despite Market Risks, Analyst Says ↗

July 05, 2023

H.C.

Via Benzinga

Biotricity's Return On Capital Employed Overview ↗

July 03, 2023

Via Benzinga

Biotricity: Q4 Earnings Insights ↗

June 30, 2023

Via Benzinga

Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 05, 2023

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...

Via Benzinga

Biotricity Announces Reverse Stock Split

June 30, 2023

Via ACCESSWIRE

Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow

June 30, 2023

Via ACCESSWIRE

Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th

June 26, 2023

Via ACCESSWIRE

Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare

May 23, 2023

Via ACCESSWIRE

Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth

May 16, 2023

Via ACCESSWIRE

Nike, Constellation Brands And 3 Stocks To Watch Heading Into Friday ↗

June 30, 2023

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Markets Turn More Bullish As Bank Shares Rise On Stress Test Results ↗

June 30, 2023

The CNN Money Fear and Greed index showed further increase in overall sentiment among U.S. investors on Thursday.

Via Benzinga

FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?

June 21, 2023

FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?

Via News Direct

FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular? ↗

June 20, 2023

The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include viol

Via Benzinga

Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland

May 10, 2023

Via ACCESSWIRE

Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report

April 11, 2023

Via ACCESSWIRE

Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation

March 07, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 24, 2023

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products

April 21, 2023

Via ACCESSWIRE

New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products ↗

April 20, 2023

Biotricity Inc. (NASDAQ: BTCY), a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease prevention and management, is taking action to tackle...

Via Benzinga

Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead

April 19, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 16, 2023

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com